H35.313

Clinical Causes: Aging: The primary risk factor as the condition mainly affects older adults. Genetic predisposition: Family history and inherited genetic factors can increase risk. Environmental influences: Smoking, poor diet, and exposure to sunlight are linked to higher risk. Cardiovascular health: Conditions like hypertension and high cholesterol may contribute to AMD development. Oxidative stress: Accumulation of free radicals can damage retinal cells over time.

Key Symptoms: Blurry or distorted central vision, especially when viewing objects directly ahead. Dark or empty areas in the central field of vision. Gradual loss of sharpness in the central vision that worsens over time. Difficulty recognizing faces or reading small print. Absence of pain or discomfort, as AMD generally doesn't cause physical pain.

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination including visual acuity tests and detailed inspection using tools such as dilated retinal examination. Fundus photography and optical coherence tomography (OCT) are often utilized to assess the extent of macular changes. These imaging techniques help identify drusen (yellow deposits under the retina), which are characteristic features of dry AMD. Regular eye check-ups are essential for early detection and monitoring of disease progression.

Treatment Protocols: Nutritional supplements: High-dose formulations containing vitamins C and E, zinc, copper, and antioxidants may help reduce progression in some cases. Lifestyle modifications: Quitting smoking, adopting a healthy diet rich in green leafy vegetables, and managing cardiovascular risk factors are recommended. Regular monitoring: Routine eye exams help track disease changes and adjust management plans accordingly. Assistive devices: The use of magnifying lenses or electronic vision aids can assist individuals with vision loss. Emerging therapies: Ongoing research explores potential treatments like laser therapy and gene therapy, though these are not yet standard care.